Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
Provided By GlobeNewswire
Last update: May 16, 2024
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will participate in a fireside chat and be available for one-on-one meetings at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ, to take place on Monday, May 20, 2024, at the NASDAQ World Headquarters New York, NY. Details are as follows:
NASDAQ:SPRO (6/2/2025, 11:43:07 AM)
2.88
+0.38 (+15.2%)
Find more stocks in the Stock Screener
SPRO Latest News and Analysis
3 days ago - ChartmillUnusual volume stocks in Friday's sessionLet's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session.
4 days ago - ChartmillThe trading volume of these stocks is deviating from the norm in today's session.Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
5 days ago - ChartmillThese stocks are making the most noise in today's session.Let's dive into the action on the US markets on Wednesday. Here are the most active stocks that are driving the market today.
